Myeloma Novel Drug Discovery Ver 1.2
Myeloma Novel Drug Discovery Ver 1.2
Recruiting · NCT05968417 · Registry updated 2023-08-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Myeloma Novel Drug Discovery Ver 1.2 | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Not stated | 2023-08-03 | NCT05968417 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institute of Cancer Research, United Kingdom | 59 |
| Royal Marsden NHS Foundation Trust | 89 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Royal Marsden NHS Foundation Trust | Sutton | United Kingdom | 1 |